FAKTOR OPTIONSSCHEIN - ROCHE GS Share Price

Certificat

DE000PC9R0G7

Market Closed - Deutsche Boerse AG 15:21:13 20/06/2024 BST
0.222 EUR -0.89% Intraday chart for FAKTOR OPTIONSSCHEIN - ROCHE GS
Current month+91.38%
1 month+45.10%
Date Price Change
20/06/24 0.222 -0.89%
19/06/24 0.224 +10.34%
18/06/24 0.203 +4.64%
17/06/24 0.194 -5.37%
14/06/24 0.205 +7.89%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 03:21 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC9R0G
ISINDE000PC9R0G7
Date issued 04/05/2022
Strike 249.8 CHF
Maturity Unlimited
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 93.36
Lowest since issue 0.072
Spread 0.004
Spread %1.76%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
250 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.22%
Consensus